The Manila Times23h
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
The Company is planning to announce interim data from its ongoing Halneuron ® Phase 2b chemotherapy induced neuropathic pain ("CINP”) trial in Q4 2025 ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- ...
Inquirer.net2d
House bill pushes mandatory SEC, PSA registration for religious groups
A House lawmaker wants a national registry and accreditation system created for churches, sects, and religious groups to ...
SWI swissinfo.ch2d
Swiss Senate backs stricter rules for systemically important banks
The Swiss Senate has adopted a motion calling for stricter rules for systemically important banks following the Credit Suisse ...